Clinical ProgressThe safety review committee has approved opening of Cohort 4 in the Phase 1 trial evaluating TTX-MC138 in advanced/metastatic solid tumors, based on favorable safety observed in previous cohorts.
Safety And TolerabilityNo safety issues observed to date in the Phase 1 trial; several patients from Cohort 1 and 2 remain on study.
Strategic GrowthThe company is engaged in potential pipeline partnerships, indicating strategic growth opportunities following the presentation of initial data.